Gsk (GSK) Cost of Revenue (2009 - 2026)
Gsk (GSK) posted Cost of Revenue of $5.56 billion for the quarter ended Sep 8, 2026.
Gsk (GSK) Cost of Revenue (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 8, 2026, Cost of Revenue at Gsk was $23.12 billion; for the year ended Dec 31, 2025, it was $11.89 billion, up 2.8% from the prior year.
- Annual Cost of Revenue shows a five-year compound annual growth rate of 3.1% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Cost of Revenue was $11.57 billion in the year ended Dec 31, 2024 (+8.6%), $10.65 billion in the year ended Dec 31, 2023 (-9.9%), $11.82 billion in the year ended Dec 31, 2022 (+5.3%) and $11.23 billion in the year ended Dec 31, 2021 (+10.3%).
- Quarterly Cost of Revenue has run from a low of $2.36 billion in the quarter ended Mar 31, 2023 to a high of $11.99 billion in the quarter ended Dec 31, 2025 over five years.
- On a year-over-year basis, Cost of Revenue increased in five of the last seven quarters, with growth averaging 3.5%.
- The strongest year-over-year quarter for Cost of Revenue in the past five years was the quarter ended Dec 31, 2022, with growth of 198.5%; the weakest was the quarter ended Mar 31, 2023, with a decline of 35.2%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 3.04 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.04 Bn |
| Mar 31, 2026 | 2.53 Bn |
| Dec 31, 2025 | 11.99 Bn |
| Sep 30, 2025 | 3.05 Bn |
| Jun 30, 2025 | 2.89 Bn |
| Mar 31, 2025 | 2.44 Bn |
| Dec 31, 2024 | 11.61 Bn |
| Sep 30, 2024 | 3.11 Bn |
| Jun 30, 2024 | 2.68 Bn |
| Mar 31, 2024 | 2.50 Bn |
| Dec 31, 2023 | 10.63 Bn |
| Sep 30, 2023 | 2.88 Bn |
| Jun 30, 2023 | 2.42 Bn |
| Mar 31, 2023 | 2.36 Bn |
| Dec 31, 2022 | 11.21 Bn |
| Sep 30, 2022 | 2.86 Bn |
| Jun 30, 2022 | 2.74 Bn |
| Mar 31, 2022 | 3.65 Bn |
| Dec 31, 2021 | 3.75 Bn |
| Sep 30, 2021 | 2.78 Bn |
Gsk Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();